Therefore, in clinic, when we take biopsy samples from CRC patients by endoscopy, and evaluate the expression levels of ezrin preoperatively, we are able to evaluate the risk of LN metastases in CRC patients, and to decide the strategy of treatment, preoperatively. This evidence concerns the gene EZR and colorectal carcinoma.